Enzo Biochem Posts Decline in Q4 Revenues; Company Realignment | GenomeWeb

NEW YORK (GenomeWeb News) – Enzo Biochem announced after the close of the market Monday that its fourth-quarter revenues declined a little more than 1 percent year over year as the firm began a realignment of its operations aimed at reducing its cash burn.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.